Global Topical Corticosteroids Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Dermatological Disorders
![]() |
Topical Corticosteroids Market |
The
global topical corticosteroids market is estimated to be valued at US$ 4.12
billion in 2022 and is expected to exhibit a CAGR of 4.36% over the forecast
period (2022-2030), as highlighted in a new report published by Coherent Market
Insights.
A) Market Overview:
Topical corticosteroids are widely used in the treatment of various
dermatological disorders such as eczema, psoriasis, and dermatitis. These
medications reduce inflammation, itching, and redness associated with these
conditions. The advantages of topical corticosteroids include targeted
application, rapid relief of symptoms, and minimal systemic absorption, which
reduces the risk of systemic side effects. The increasing prevalence of
dermatological disorders and the growing demand for effective treatment options
are driving the growth of the global topical corticosteroids market.
B) Market Key Trends:
One key trend observed in the global Topical
Corticosteroids Market is the advent of novel formulations and drug
delivery systems. Pharmaceutical companies are focusing on developing
innovative formulations that enhance drug penetration into the skin, improve
efficacy, and minimize side effects. For example, the development of foam-based
formulations has gained traction due to their ease of use and better absorption
compared to traditional creams and ointments. This trend is expected to drive
market growth as it improves patient compliance and outcomes.
C) PEST Analysis:
Political: The regulatory landscape plays a crucial role in the topical
corticosteroids market. Stringent regulations regarding the safety and efficacy
of these medications are imposed by regulatory authorities to ensure patient
safety.
Economic: The increasing healthcare expenditure and rising disposable income in
developing countries are contributing to the growth of the market.
Additionally, the affordability and availability of generic topical
corticosteroids are driving market growth.
Social: The growing awareness about skin health and the availability of
advanced treatment options are influencing patient behavior, leading to
increased adoption of topical corticosteroids.
Technological: Technological advancements in drug delivery systems, such as
nanomedicine and transdermal patches, are paving the way for novel formulations
that improve drug delivery and efficacy.
D) Key Takeaways:
1. The global Topical
Corticosteroids Market is expected to witness high growth, exhibiting a
CAGR of 4.36% over the forecast period, due to increasing prevalence of
dermatological disorders. The rising incidence of conditions such as eczema,
psoriasis, and dermatitis is driving the demand for effective treatment
options.
2. North America is expected to dominate the market during the forecast period.
The region has a well-established healthcare infrastructure, high healthcare
expenditure, and a large patient population. Additionally, the presence of key
market players in North America contributes to its dominance.
3. Key players operating in the global topical corticosteroids market include
GlaxoSmithKline plc, Merck & Co., Inc., Sandoz International GmbH,
AstraZeneca, LEO Pharma, Cipla Inc., Bristol-Myers Squibb Company, Almirall,
S.A., Bausch Health, and Sanofi SA. These companies are focusing on product
development, strategic collaborations, and mergers and acquisitions to
strengthen their market position.
In conclusion, the global topical corticosteroids market is poised for
significant growth due to the increasing prevalence of dermatological disorders
and the development of novel formulations. The market is driven by technological
advancements, favorable economic factors, and changing patient behavior. Key
players in the market are implementing strategies to capitalize on these
opportunities and strengthen their presence in the market.
Comments
Post a Comment